Attached files
| file | filename |
|---|---|
| EX-10.47 - EX-10.47 - ReShape Lifesciences Inc. | d80242dex1047.htm |
| EX-10.45 - EX-10.45 - ReShape Lifesciences Inc. | d80242dex1045.htm |
| EX-10.33 - EX-10.33 - ReShape Lifesciences Inc. | d80242dex1033.htm |
| EX-32.2 - EX-32.2 - ReShape Lifesciences Inc. | d80242dex322.htm |
| EX-31.2 - EX-31.2 - ReShape Lifesciences Inc. | d80242dex312.htm |
| EX-32.1 - EX-32.1 - ReShape Lifesciences Inc. | d80242dex321.htm |
| 10-K - 10-K - ReShape Lifesciences Inc. | d80242d10k.htm |
| EX-31.1 - EX-31.1 - ReShape Lifesciences Inc. | d80242dex311.htm |
EXHIBIT 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statement Nos. 333-196646, 333-184181, 333-176174, 333-171244, 333-159592, and 333-149662 on Form S-8 and Registration Statement Nos.333-205353, 333-195855, 333-171944, 333-170503, 333-171052, 333-166011, and 333-158516 on Form S-3 of our report dated March 28, 2016, relating to the consolidated financial statements of EnteroMedics Inc. and subsidiary, appearing in this Annual Report on Form 10-K of the Company for the year ended December 31, 2015.
| /s/ DELOITTE & TOUCHE LLP |
| Minneapolis, MN |
| March 28, 2016 |